O00255 (MEN1_HUMAN) Homo sapiens (Human)

Menin UniProtKBInterProSTRINGInteractive Modelling

610 aa; Sequence (Fasta) ; (Isoform 1; Isoform 3)

Available Structures

47 Experimental Structures

DescriptionPDB IDOligo-stateRangeSeq id (%)Ligands
Human menin in complex with MLL peptide Heteromer
Q03164;
2-588
100SO4;1PE;
Human menin in complex with H3K79Me2 nucleosome Heteromer
P02281; P06897; P62799; P84233;
2-587
100.0
Crystal structure of human menin in complex with MLL1 and LEDGF Heteromer
O75475; Q03164;
2-583
100.0CHD;GGB;0BR;GLV;SO4;
Crystal structure of human menin in complex with JunD Heteromer
P17535;
2-581
100.0
Crystal structure of human menin in complex with MLL1 Heteromer
Q03164;
2-581
100.0
Crystal structure of menin in complex with DS-1594bhomo-2-mer2-584
100.07IX;UNX;DMS;
Crystal structure of human menin in complex with a high-affinity macrocyclic peptidomimeticshomo-2-mer2-581
100.0
Inhibition of Human Menin by SNDX-5613homo-2-mer2-457
99.53OQ4;EDO;MES;
Inhibition of Human Menin by SNDX-5613homo-2-mer2-457
99.76OQ4;MG;
Crystal Structure of Human Meninmonomer2-608
100.0
Structural insights into inhibition of the bivalent menin-MLL interaction by small molecules in leu…monomer2-589
100PEG;PG4;EPE;
Menin in complex with MI-352monomer2-589
100PG4;SO4;DMS;58P;6E6;
Menin in complex with MI-389monomer2-589
10058R;DMS;PG4;SO4;PEG;
Menin in complex with MI-503monomer2-589
1003XW;DMS;PG4;SO4;EDO;EPE;
Menin in complex with MI-326monomer2-589
10059K;DMS;PG4;PGE;SO4;
Menin in complex with MI-3454monomer2-588
100LMY;DMS;SO4;PG4;
Human menin with bound inhibitor MI-2-2monomer2-588
1000RT;UNX;EPE;SO4;PE4;DMS;
Human menin with bound inhibitor MIV-3Smonomer2-588
100SO4;2VK;PG4;PGE;PEG;DMS;TBF;
Human menin with bound inhibitor MIV-4monomer2-588
100SO4;2S9;PG4;PEG;DMS;
Menin in complex with peptide inhibitor 25monomer2-588
100DMS;SO4;PG4;
Human menin with bound inhibitor MIV-6Rmonomer2-588
100TBF;2SF;PG4;SO4;DMS;PGA;
Human menin with bound inhibitor MI-2monomer2-588
1000RO;PEG;UNX;SO4;
Menin in complex with MI-2-3monomer2-588
10059V;DMS;PGE;PEG;EPE;
Human menin with bound inhibitor MIV-5monomer2-588
1002S7;SO4;PG4;PEG;DMS;TBF;
Menin in complex with MI-574monomer2-588
100DMS;PG4;SO4;PEG;58Q;
Menin in complex with MI-859monomer2-588
1005A0;SO4;DMS;PG4;EDO;
Menin in complex with MI-1481monomer2-588
100EEV;DMS;PG4;SO4;EDO;
Menin in complex with MI-336monomer2-588
10058O;DMS;SO4;PG4;
menin in complex with MI-136monomer2-588
100SO4;3XY;PG4;DMS;EDO;
Menin in complex with MI-1482monomer2-588
100FNV;DMS;PG4;SO4;EDO;
Human menin with bound inhibitor MIV-7monomer2-588
100SO4;2SE;PGE;PEG;DMS;
menin in complex with MI-836monomer2-588
10059X;SO4;DMS;PG4;PEG;
Menin in complex with MI-273monomer2-587
1005A1;DMS;PG4;PEG;SO4;
Menin in complex with MI-333monomer2-587
10059M;DMS;PGE;EDO;SO4;
Menin in complex with MI-319monomer2-586
10059Q;DMS;PG4;PEG;SO4;
Human menin with bound inhibitor MIV-3Rmonomer2-586
100SO4;2S6;PG4;PEG;DMS;
Inhibition of Human Menin by VTP-50469monomer2-583
99.77OP4;
Crystal structure of Human Menin in complex with BD-08monomer1-582
100V6N;EDO;GOL;
Crystal structure of Human Menin in complex with Fragment 21monomer1-582
100V6K;EDO;GOL;
Crystal structure of Human Menin in apo formmonomer1-582
100EDO;
Crystal structure of Human Menin with fragment 16monomer1-582
100V6Q;GOL;EDO;
Menin bound to inhibitor M-808monomer2-581
100.07MM;7PR;
Menin bound to M-525monomer2-581
100.0CJV;7PR;
Menin bound to M-1121monomer2-581
100.0YQV;7PR;
Menin bound to M-89monomer2-581
100.0HL7;7PR;
Human Menin in complex with AJ21monomer3-581
100.0
Menin in complex with MI-853monomer2-459
100.0DMS;SO4;EE7;

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
3u84.1.Amonomer0.772-608
99.27

2 SWISS-MODEL models built on isoform sequence

IsoformTemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 13u84.1.Amonomer0.772-613
99.27
Isoform 33u84.1.Amonomer0.782-572
99.22